Multiple Sclerosis in a Patient with Intermediate Uveitis and Juvenile Idiopathic Arthritis Treated with Adalimumab: A Case Report.
William Rojas-CarabaliLaura Boada-RobayoDaniela Chacón-ZambranoEveling Criollo PorrasValentina Kerguelén DumarAlejandra de-la-TorrePublished in: Ocular immunology and inflammation (2022)
We reported the first case of MS development in a patient with JIA treated with Adalimumab and the third in a patient with noninfectious uveitis treated with anti-TNFα. It remains uncertain whether MS is secondary to anti-TNFα therapy or is linked to a polyautoimmunity phenomenon.